Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (271-280 of 395) with videos related to

Pageof 40
Sort By:
Biologics : Targets & Therapy|February 28, 2020
Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre StudyMarco A Cimmino, Massimiliano Parodi, Francesca Barbieri, et al.
RMD Open|September 29, 2017
Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go nextReuven Mader, Jorrit-Jan Verlaan, Iris Eshed, et al.
Cytometry. Part B, Clinical Cytometry|January 22, 2017
Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead-based FACS CANTO II cytometersValentina Grossi, Maria Infantino, Francesca Meacci, et al.
Clinical and Experimental Rheumatology|June 20, 2015
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar yearsFlorenzo Iannone, Fausto Salaffi, Antonio Marchesoni, et al.
Rheumatology (Oxford, England)|October 1, 2009
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritisLuca Quartuccio, Martina Fabris, Sara Salvin, et al.
Autoimmunity|January 8, 2008
Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndromePiercarlo Sarzi-Puttini, Fabiola Atzeni, Manuela Di Franco, et al.
EULAR Rheumatology Open|June 29, 2026
Healthcare providers' awareness and knowledge of recommendations on cardiovascular risk management in people with rheumatic and musculoskeletal diseases: a survey studyDina Husum, Julie Katrine Karstensen, Massimo Radin, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experimentLuca Quartuccio, Matteo Piga, Fabiola Atzeni, et al.
Disease Markers|September 16, 2017
Measurement of Serum Klotho in Systemic SclerosisRossella Talotta, Sara Bongiovanni, Teresa Letizia, et al.
The Journal of Rheumatology|February 17, 2016
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian StudyValentina Varisco, Mauro Viganò, Alberto Batticciotto, et al.
Pageof 40

Showing results (271-280 of 395) with videos related to

Sort By:
Pageof 40
Biologics : Targets & Therapy|February 28, 2020
Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre StudyMarco A Cimmino, Massimiliano Parodi, Francesca Barbieri, et al.
RMD Open|September 29, 2017
Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go nextReuven Mader, Jorrit-Jan Verlaan, Iris Eshed, et al.
Cytometry. Part B, Clinical Cytometry|January 22, 2017
Comparison of methods and TAT assessment: Volumetric AQUIOS CL and bead-based FACS CANTO II cytometersValentina Grossi, Maria Infantino, Francesca Meacci, et al.
Clinical and Experimental Rheumatology|June 20, 2015
Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar yearsFlorenzo Iannone, Fausto Salaffi, Antonio Marchesoni, et al.
Rheumatology (Oxford, England)|October 1, 2009
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritisLuca Quartuccio, Martina Fabris, Sara Salvin, et al.
Autoimmunity|January 8, 2008
Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndromePiercarlo Sarzi-Puttini, Fabiola Atzeni, Manuela Di Franco, et al.
EULAR Rheumatology Open|June 29, 2026
Healthcare providers' awareness and knowledge of recommendations on cardiovascular risk management in people with rheumatic and musculoskeletal diseases: a survey studyDina Husum, Julie Katrine Karstensen, Massimo Radin, et al.
Clinical and Experimental Rheumatology|September 12, 2024
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experimentLuca Quartuccio, Matteo Piga, Fabiola Atzeni, et al.
Disease Markers|September 16, 2017
Measurement of Serum Klotho in Systemic SclerosisRossella Talotta, Sara Bongiovanni, Teresa Letizia, et al.
The Journal of Rheumatology|February 17, 2016
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian StudyValentina Varisco, Mauro Viganò, Alberto Batticciotto, et al.
Pageof 40